FDA Import Refusal SCS-8997116-6/41/1 — DONGKOOK PHARMACEUTICAL CO., LTD.
The FDA refused shipment SCS-8997116-6/41/1 from DONGKOOK PHARMACEUTICAL CO., LTD. (South Korea) on Mar 14, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,472,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Mar 14, 2025
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VBA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,472,75